Samantha K. Holden
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Samantha K. Holden has a total of 158 co-authors. Here are the top co-authors by number of shared publications:
Brianne M. Bettcher
Department of Neurology, University of Colorado School of Medicine, Aurora, CO, United States
4 shared publications- Jennifer G. Goldman
JPG Enterprises LLC (prior: Shirley Ryan Ability Lab and Northwestern University Feinberg School of Medicine
4 shared publications Victoria S. Pelak
Department of Neurology, University of Colorado School of Medicine, Aurora, CO, United States
4 shared publications- Brian D. Berman
Department of Neurology, Virginia Commonwealth University, United States
3 shared publications Glenn T. Stebbins
Department of Neurological Sciences, Section of Parkinson Disease and Movement Disorders, Rush University Medical Center, Chicago, Illinois, USA
3 shared publicationsIrene Litvan
Department of Neurosciences, University of California San Diego, La Jolla, USA
3 shared publications
Latest Publications
- Open Access
- 3 November 2026
- Published by Springer Nature in npj Parkinson's Disease
An exploratory remote pilot study of environmental risk factors for Lewy body dementia considering sex differences
Lewy body dementia (LBD), including Parkinson’s disease dementia (PDD) and dementia with Lewy bodies (DLB), is a common dementia that currently lacks disease modification. While studies in Alzheimer’s and Parkinson’s diseases underscore the contribution of environmental factors with sex differences, knowledge on LBD environmental risk factors remains limited. We conducted an exploratory remote pilot survey, including data on residential history, chemical exposure, smoking, and alcohol use, for people with LBD ( n = 130; 51 females, 79 males) and age-matched controls ( n = 124; 64 females, 60 males). Associations with LBD risk for each environmental factor were assessed in the overall cohort and stratified by sex and LBD subtype (DLB or PDD). Metal exposure was associated with a higher risk of LBD. Alcohol and smoking were associated with a higher risk, particularly for males; glue/adhesives and not living in the suburbs were associated with a higher risk, particularly for females. Environmental factors likely play a role in LBD with potential sex differences.
- 3 November 2026
- Published by Springer Nature in npj Parkinson's Disease
Open AccessAn exploratory remote pilot study of environmental risk factors for Lewy body dementia considering sex differences
Lewy body dementia (LBD), including Parkinson’s disease dementia (PDD) and dementia with Lewy bodies (DLB), is a common dementia that currently lacks disease modification. While studies in Alzheimer’s and Parkinson’s diseases underscore the contribution of environmental factors with sex differences, knowledge on LBD environmental risk factors remains limited. We conducted an exploratory remote pilot survey, including data on residential history, chemical exposure, smoking, and alcohol use, for people with LBD ( n = 130; 51 females, 79 males) and age-matched controls ( n = 124; 64 females, 60 males). Associations with LBD risk for each environmental factor were assessed in the overall cohort and stratified by sex and LBD subtype (DLB or PDD). Metal exposure was associated with a higher risk of LBD. Alcohol and smoking were associated with a higher risk, particularly for males; glue/adhesives and not living in the suburbs were associated with a higher risk, particularly for females. Environmental factors likely play a role in LBD with potential sex differences.
- Open Access
- 10 June 2026
- Published by Springer Nature in Neurology and Therapy
- Vol. 15 (4) , 1945-1971
Descriptive Analysis of Retrospective Observational Real-World Evidence of a Monoclonal Anti-Amyloid Therapy Program in a Wide Catchment Specialty Memory Clinic
Anti-amyloid therapy (AAT) protocol complexity may widen specialty dementia care access gaps. The University of Colorado (CU) Advanced Therapy in Neurodegenerative Disorders (ATND) Clinic is within the CU-Memory Disorders Clinic (CU-MDC). The aim of this study is to report initial CU-ATND real-world evidence (RWE). Patients who completed CU-ATND Clinic intake paperwork were included (n = 123) and compared to CU-MDC (n = 1100) seen between April 2024 to June 2025. Demographic information was included for both clinics. Retrospective observational data on CU-ATND Clinic patients including work-up, decisions about pursing AAT, and adverse events at the time of data extraction was described. AAT status included patient declined (37.4%) or deferred (8.1%), clinically excluded (14.6%), undergoing work-up (8.1%), consented for infusions (26.0%), completed infusions (0.8%), and stopped infusions (4.1%). CU-ATND Clinic patients had a median age of 73 years and were 50.4% women with the majority white and urban-dwelling similar to the CU-MDC. AAT candidacy steps and decision duration varied. AAT-related adverse events were managed without extended inpatient admission or persistent effects. Many care disparities were present prior to CU-ATND referral. The CU-ATND RWE highlights successes and provides insight into barriers impacting access.
- 10 June 2026
- Published by Springer Nature in Neurology and Therapy
- Vol. 15 (4) , 1945-1971
Open AccessDescriptive Analysis of Retrospective Observational Real-World Evidence of a Monoclonal Anti-Amyloid Therapy Program in a Wide Catchment Specialty Memory Clinic
Anti-amyloid therapy (AAT) protocol complexity may widen specialty dementia care access gaps. The University of Colorado (CU) Advanced Therapy in Neurodegenerative Disorders (ATND) Clinic is within the CU-Memory Disorders Clinic (CU-MDC). The aim of this study is to report initial CU-ATND real-world evidence (RWE). Patients who completed CU-ATND Clinic intake paperwork were included (n = 123) and compared to CU-MDC (n = 1100) seen between April 2024 to June 2025. Demographic information was included for both clinics. Retrospective observational data on CU-ATND Clinic patients including work-up, decisions about pursing AAT, and adverse events at the time of data extraction was described. AAT status included patient declined (37.4%) or deferred (8.1%), clinically excluded (14.6%), undergoing work-up (8.1%), consented for infusions (26.0%), completed infusions (0.8%), and stopped infusions (4.1%). CU-ATND Clinic patients had a median age of 73 years and were 50.4% women with the majority white and urban-dwelling similar to the CU-MDC. AAT candidacy steps and decision duration varied. AAT-related adverse events were managed without extended inpatient admission or persistent effects. Many care disparities were present prior to CU-ATND referral. The CU-ATND RWE highlights successes and provides insight into barriers impacting access.
- Open Access
- 25 March 2026
- Published by Wolters Kluwer Health in Cognitive and Behavioral Neurology
- Vol. 39 (2) , 64-73
Refining the Parkinson’s Disease Risk Estimator for Decline In Cognition Tool (PREDICT)
Background: Although cognitive decline in Parkinson disease (PD) is common, there are currently no easily accessible clinical tools to predict the risk of cognitive decline in PD. Objective: To refine a tool to predict cognitive decline in PD and identify potentially modifiable factors. Methods: We used neuropsychological scores from the Parkinson’s Progression Markers Initiative de novo PD cohort to calculate a composite cognitive score (CCS) for each participant. Participants with a decrease of ≥0.5 SD in CCS between baseline and Year 4 were considered to have cognitive decline (PD-Decline), as predicted by conditional linear mixed modeling to account for nonignorable dropouts. We identified risk factors for PD-Decline using logistic regression and developed the PD Risk Estimator for Decline In Cognition Tool (PREDICT) scoring system using the regression β coefficients. The selected risk factors and the discriminative ability of the PREDICT scoring system were evaluated using bootstrapped samples. Results: Participants with excessive daytime sleepiness (odds ratio [OR]=2.8; 95% CI [1.3, 6.0]), moderate-severe motor symptoms (OR=2.6; 95% CI [1.2, 5.4]), and fewer years of formal education (OR=2.2; 95% CI [1.1, 4.1]) had significantly increased odds of being categorized as PD-decline. Possible PREDICT scores ranged from 0 to 3.5. The average bootstrap sensitivity and specificity were 59.9% and 43.5%, respectively. Conclusion: We identified excessive daytime sleepiness and moderate-severe motor symptoms as potentially modifiable factors. In the future, PREDICT may offer wider opportunities for personalized risk assessment and potential risk reduction.
- 25 March 2026
- Published by Wolters Kluwer Health in Cognitive and Behavioral Neurology
- Vol. 39 (2) , 64-73
Open AccessRefining the Parkinson’s Disease Risk Estimator for Decline In Cognition Tool (PREDICT)
Background: Although cognitive decline in Parkinson disease (PD) is common, there are currently no easily accessible clinical tools to predict the risk of cognitive decline in PD. Objective: To refine a tool to predict cognitive decline in PD and identify potentially modifiable factors. Methods: We used neuropsychological scores from the Parkinson’s Progression Markers Initiative de novo PD cohort to calculate a composite cognitive score (CCS) for each participant. Participants with a decrease of ≥0.5 SD in CCS between baseline and Year 4 were considered to have cognitive decline (PD-Decline), as predicted by conditional linear mixed modeling to account for nonignorable dropouts. We identified risk factors for PD-Decline using logistic regression and developed the PD Risk Estimator for Decline In Cognition Tool (PREDICT) scoring system using the regression β coefficients. The selected risk factors and the discriminative ability of the PREDICT scoring system were evaluated using bootstrapped samples. Results: Participants with excessive daytime sleepiness (odds ratio [OR]=2.8; 95% CI [1.3, 6.0]), moderate-severe motor symptoms (OR=2.6; 95% CI [1.2, 5.4]), and fewer years of formal education (OR=2.2; 95% CI [1.1, 4.1]) had significantly increased odds of being categorized as PD-decline. Possible PREDICT scores ranged from 0 to 3.5. The average bootstrap sensitivity and specificity were 59.9% and 43.5%, respectively. Conclusion: We identified excessive daytime sleepiness and moderate-severe motor symptoms as potentially modifiable factors. In the future, PREDICT may offer wider opportunities for personalized risk assessment and potential risk reduction.
- Open Access
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S19)
Comparison of LBD research priorities by caregiver characteristics
Background: Caregivers of individuals with Lewy body dementia (LBD) experience high levels of caregiver burden while having a pivotal role in clinical and research decision‐making. Despite the importance of the caregivers in LBD, little is known about their research priorities. Targeting these priorities may help research engagement and more meaningful study aims.Method: A web‐based survey of current and former caregivers of people with LBD investigated research priorities through forced ranking and exploration of experiences in LBD. Importance of research topics were queried and further analyzed descriptively based on age, gender, relationship type (spouse, sibling, adult child), and location type (large city, suburb, small town, rural). Race and ethnicity were not included due to small sample size.Result: Between 4/7/2021‐7/1/2021, 984 responses were recorded: 550 identified as current caregivers and 280 as former caregivers. Younger caregivers (<60 years) were more likely to express interest in research participation, as were those residing in large cities. No difference in research interest was seen between caregiver gender or relationship type. The top research priority for all caregivers was development of disease modifying therapy. More women were interested in LBD‐specific healthcare education. Both women and adult children caregivers prioritized identifying individuals at risk for LBD. Spouses prioritized understanding disease course and progression, whereas siblings prioritized pathophysiological changes and alternative medicine approaches. Individuals from large cities and suburbs prioritized medication development and those from rural areas and small cities valued improving methods to diagnose LBD.Conclusion: This study emphasizes varying research priorities based on age, gender, relationship, and area of residence of LBD caregivers. Recognition of the heterogeneity of LBD caregivers allows for personalized outreach and support, as well as tailored research projects and goals. Identifying the unique priorities of those personally affected by LBD can guide research development towards maximally impactful outcomes.
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S19)
Open AccessComparison of LBD research priorities by caregiver characteristics
Background: Caregivers of individuals with Lewy body dementia (LBD) experience high levels of caregiver burden while having a pivotal role in clinical and research decision‐making. Despite the importance of the caregivers in LBD, little is known about their research priorities. Targeting these priorities may help research engagement and more meaningful study aims.Method: A web‐based survey of current and former caregivers of people with LBD investigated research priorities through forced ranking and exploration of experiences in LBD. Importance of research topics were queried and further analyzed descriptively based on age, gender, relationship type (spouse, sibling, adult child), and location type (large city, suburb, small town, rural). Race and ethnicity were not included due to small sample size.Result: Between 4/7/2021‐7/1/2021, 984 responses were recorded: 550 identified as current caregivers and 280 as former caregivers. Younger caregivers (<60 years) were more likely to express interest in research participation, as were those residing in large cities. No difference in research interest was seen between caregiver gender or relationship type. The top research priority for all caregivers was development of disease modifying therapy. More women were interested in LBD‐specific healthcare education. Both women and adult children caregivers prioritized identifying individuals at risk for LBD. Spouses prioritized understanding disease course and progression, whereas siblings prioritized pathophysiological changes and alternative medicine approaches. Individuals from large cities and suburbs prioritized medication development and those from rural areas and small cities valued improving methods to diagnose LBD.Conclusion: This study emphasizes varying research priorities based on age, gender, relationship, and area of residence of LBD caregivers. Recognition of the heterogeneity of LBD caregivers allows for personalized outreach and support, as well as tailored research projects and goals. Identifying the unique priorities of those personally affected by LBD can guide research development towards maximally impactful outcomes.
- Open Access
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S20)
Effect of COVID‐19 and telehealth implementation on Patient Centered Outcome Measures completion by patients with Alzheimer’s and related disorders in an academic memory center
Background: Patient Centered Outcome Measures (PCOMs) are increasingly recognized as a means of improving clinical efficiency, particularly when completed electronically ahead of clinic visits. However, PCOM completion is often far from consistent. The shift to telehealth introduced by the Covid‐19 pandemic changed how patients and caregivers engaged with medical care, possibly encouraging increased participation in electronic assessments. We questioned how the pandemic influenced electronic PCOM completion by our patients with Alzheimer’s disease (AD) and their caregivers.Methods: Patients and caregivers were routinely invited to fill electronic PCOM questionnaires prior to visits both before and during the Covid‐19 pandemic. PCOMs assessed the predominant cognitive domain of concern, other diagnostically useful symptoms, disease severity, neuropsychiatric symptoms, and caregiver wellbeing. A date of 3/15/2020 was set as the onset of the pandemic for this study, after which time our clinic converted to telehealth visits only. We tallied rates of completion of electronic surveys by patients and/or caregivers three and a half months before and after that time, comparing completion rates by two proportion Z‐test.Results: During this timeframe, across a total of 402 visits (total: 333 individuals, 69 returns; AD: 73 individuals, 6 returns), caregivers and/or patients were offered an opportunity to fill PCOMs ahead of the visit. Across all clinical diagnoses combined, the probability of a visit being associated with filled PCOMS was greater after switching to only telehealth (caregivers: P = 0.005,patients: P = 0.016). Additionally,after the shift to telehealth, AD‐related visits were twice as likely to have completed preclinical electronic PCOMs (caregivers: P = 0.002, patients: P = 0.008). Approximately 33.3% of PCOMS to be filled by AD caregivers were completed before the telehealth shift, and 67.5% were afterwards. Approximately 26.7% of patient PCOMs were filled before the change, and afterwards this percentage rose to 55.0%.Conclusion: The beginning of the Covid‐19 pandemic and subsequent shift towards telehealth‐only practice was associated with greater use of electronic PCOMs by all patients, including those with AD and their caregivers. Increased acceptance of electronic PCOMs seems to offer promising opportunities for remote assessment in the future of dementia diagnosis and care.
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S20)
Open AccessEffect of COVID‐19 and telehealth implementation on Patient Centered Outcome Measures completion by patients with Alzheimer’s and related disorders in an academic memory center
Background: Patient Centered Outcome Measures (PCOMs) are increasingly recognized as a means of improving clinical efficiency, particularly when completed electronically ahead of clinic visits. However, PCOM completion is often far from consistent. The shift to telehealth introduced by the Covid‐19 pandemic changed how patients and caregivers engaged with medical care, possibly encouraging increased participation in electronic assessments. We questioned how the pandemic influenced electronic PCOM completion by our patients with Alzheimer’s disease (AD) and their caregivers.Methods: Patients and caregivers were routinely invited to fill electronic PCOM questionnaires prior to visits both before and during the Covid‐19 pandemic. PCOMs assessed the predominant cognitive domain of concern, other diagnostically useful symptoms, disease severity, neuropsychiatric symptoms, and caregiver wellbeing. A date of 3/15/2020 was set as the onset of the pandemic for this study, after which time our clinic converted to telehealth visits only. We tallied rates of completion of electronic surveys by patients and/or caregivers three and a half months before and after that time, comparing completion rates by two proportion Z‐test.Results: During this timeframe, across a total of 402 visits (total: 333 individuals, 69 returns; AD: 73 individuals, 6 returns), caregivers and/or patients were offered an opportunity to fill PCOMs ahead of the visit. Across all clinical diagnoses combined, the probability of a visit being associated with filled PCOMS was greater after switching to only telehealth (caregivers: P = 0.005,patients: P = 0.016). Additionally,after the shift to telehealth, AD‐related visits were twice as likely to have completed preclinical electronic PCOMs (caregivers: P = 0.002, patients: P = 0.008). Approximately 33.3% of PCOMS to be filled by AD caregivers were completed before the telehealth shift, and 67.5% were afterwards. Approximately 26.7% of patient PCOMs were filled before the change, and afterwards this percentage rose to 55.0%.Conclusion: The beginning of the Covid‐19 pandemic and subsequent shift towards telehealth‐only practice was associated with greater use of electronic PCOMs by all patients, including those with AD and their caregivers. Increased acceptance of electronic PCOMs seems to offer promising opportunities for remote assessment in the future of dementia diagnosis and care.
- Open Access
- 26 June 2023
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 17, 1200347
Original research: longitudinal evaluation of cognitively demanding daily function using performance-based functional assessment highlights heterogeneous trajectories in cognitive and functional abilities in people with Parkinson’s disease
Background: Longitudinal assessment of functional abilities in Parkinson’s disease (PD) is needed to determine the efficacy of cognitive interventions in providing meaningful improvements in daily life. Additionally, subtle changes in instrumental activities of daily living may precede a clinical diagnosis of dementia and could aid earlier detection of and intervention for cognitive decline.Objective: The primary goal was to validate the longitudinal application of the University of California San Diego Performance-Based Skills Assessment (UPSA). An exploratory secondary goal was to determine whether UPSA may identify individuals at higher risk of cognitive decline in PD.Methods: Seventy participants with PD completed the UPSA with at least one follow-up visit. Linear mixed effects modeling was used to identify associations between baseline UPSA score and cognitive composite score (CCS) over time. Descriptive analysis of four heterogeneous cognitive and functional trajectory groups and individual case examples was performed.Results: Baseline UPSA score predicted CCS at each timepoint for functionally impaired and unimpaired groups (p < 0.01) but did not predict the rate change in CCS over time (p = 0.83). Participants displayed heterogenous trajectories in both UPSA and CCS during the follow-up period. Most participants maintained both cognitive and functional performance (n = 54), though some displayed cognitive and functional decline (n = 4), cognitive decline with functional maintenance (n = 4), and functional decline with cognitive maintenance (n = 8).Conclusion: The UPSA is a valid measure of cognitive functional abilities over time in PD. Given the heterogeneity of functional and cognitive trajectories, this performance-based assessment did not predict cognitive decline with this relatively short follow-up. Further work is needed to understand longitudinal functional assessments in PD-associated cognitive impairment.
- 26 June 2023
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 17, 1200347
Open AccessOriginal research: longitudinal evaluation of cognitively demanding daily function using performance-based functional assessment highlights heterogeneous trajectories in cognitive and functional abilities in people with Parkinson’s disease
Background: Longitudinal assessment of functional abilities in Parkinson’s disease (PD) is needed to determine the efficacy of cognitive interventions in providing meaningful improvements in daily life. Additionally, subtle changes in instrumental activities of daily living may precede a clinical diagnosis of dementia and could aid earlier detection of and intervention for cognitive decline.Objective: The primary goal was to validate the longitudinal application of the University of California San Diego Performance-Based Skills Assessment (UPSA). An exploratory secondary goal was to determine whether UPSA may identify individuals at higher risk of cognitive decline in PD.Methods: Seventy participants with PD completed the UPSA with at least one follow-up visit. Linear mixed effects modeling was used to identify associations between baseline UPSA score and cognitive composite score (CCS) over time. Descriptive analysis of four heterogeneous cognitive and functional trajectory groups and individual case examples was performed.Results: Baseline UPSA score predicted CCS at each timepoint for functionally impaired and unimpaired groups (p < 0.01) but did not predict the rate change in CCS over time (p = 0.83). Participants displayed heterogenous trajectories in both UPSA and CCS during the follow-up period. Most participants maintained both cognitive and functional performance (n = 54), though some displayed cognitive and functional decline (n = 4), cognitive decline with functional maintenance (n = 4), and functional decline with cognitive maintenance (n = 8).Conclusion: The UPSA is a valid measure of cognitive functional abilities over time in PD. Given the heterogeneity of functional and cognitive trajectories, this performance-based assessment did not predict cognitive decline with this relatively short follow-up. Further work is needed to understand longitudinal functional assessments in PD-associated cognitive impairment.
- 12 June 2023
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 10 (8) , 1231-1232
Social Cognition Deficits in Cervical Dystonia, but not Blepharospasm: Focal Dystonias Diverge
- 12 June 2023
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 10 (8) , 1231-1232
Social Cognition Deficits in Cervical Dystonia, but not Blepharospasm: Focal Dystonias Diverge
- Open Access
- 1 February 2023
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 14, 1072938
Posterior white matter integrity and self-reported posterior cortical symptoms using the Colorado Posterior Cortical Questionnaire
Background: The Colorado Posterior Cortical Questionnaire (CPC-Q) is a self-report, 15-item screening questionnaire for posterior cortical symptoms, including visuospatial and visuoperceptual difficulties. Changes in white matter connectivity may precede obvious gray matter atrophy in neurodegenerative conditions, especially posterior cortical atrophy. Integration of CPC-Q scores and measures of white matter integrity could contribute to earlier detection of posterior cortical syndromes.Methods: We investigated the relationships between posterior cortical symptoms as captured by the CPC-Q and diffusion tensor imaging fractional anisotropy (DTI FA) of white matter regions of interest localized to posterior brain regions (posterior thalamic radiations, splenium of corpus callosum, tapetum). Comparisons were also made by diagnostic group [healthy older adult (n = 31), amnestic Alzheimer's disease (AD, n = 18), and posterior cortical atrophy (PCA, n = 9)] and by SENAS battery visuospatial composite score quartile. Exploratory comparisons of all available individual white matter region DTI FA to CPC-Q, as well as comparisons of DTI FA between diagnostic groups and visuospatial quartiles, were also made.Results: CPC-Q score was correlated with the average DTI FA for the averaged posterior white matter regions of interest (r = −0.31, p = 0.02). Posterior thalamic radiation DTI FA was most strongly associated with CPC-Q (r = −0.34, p = 0.01) and visuospatial composite (r = 0.58, p < 0.01) scores and differed between the PCA and AD groups and the lower and higher visuospatial quartiles. The DTI FA of body and splenium of the corpus callosum also demonstrated this pattern but not the DTI FA of the tapetum.Conclusion: The integrity of posterior white matter tracts is associated with scores on the CPC-Q, adding to the validation evidence for this new questionnaire. White matter regions that may be related to posterior cortical symptoms detected by the CPC-Q, and distinct from those affected in amnestic syndromes, include the posterior thalamic radiations and body and splenium of the corpus callosum. These findings are in line with previous neuroimaging studies of PCA and support continued research on white matter in posterior cortical dysfunction.
- 1 February 2023
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 14, 1072938
Open AccessPosterior white matter integrity and self-reported posterior cortical symptoms using the Colorado Posterior Cortical Questionnaire
Background: The Colorado Posterior Cortical Questionnaire (CPC-Q) is a self-report, 15-item screening questionnaire for posterior cortical symptoms, including visuospatial and visuoperceptual difficulties. Changes in white matter connectivity may precede obvious gray matter atrophy in neurodegenerative conditions, especially posterior cortical atrophy. Integration of CPC-Q scores and measures of white matter integrity could contribute to earlier detection of posterior cortical syndromes.Methods: We investigated the relationships between posterior cortical symptoms as captured by the CPC-Q and diffusion tensor imaging fractional anisotropy (DTI FA) of white matter regions of interest localized to posterior brain regions (posterior thalamic radiations, splenium of corpus callosum, tapetum). Comparisons were also made by diagnostic group [healthy older adult (n = 31), amnestic Alzheimer's disease (AD, n = 18), and posterior cortical atrophy (PCA, n = 9)] and by SENAS battery visuospatial composite score quartile. Exploratory comparisons of all available individual white matter region DTI FA to CPC-Q, as well as comparisons of DTI FA between diagnostic groups and visuospatial quartiles, were also made.Results: CPC-Q score was correlated with the average DTI FA for the averaged posterior white matter regions of interest (r = −0.31, p = 0.02). Posterior thalamic radiation DTI FA was most strongly associated with CPC-Q (r = −0.34, p = 0.01) and visuospatial composite (r = 0.58, p < 0.01) scores and differed between the PCA and AD groups and the lower and higher visuospatial quartiles. The DTI FA of body and splenium of the corpus callosum also demonstrated this pattern but not the DTI FA of the tapetum.Conclusion: The integrity of posterior white matter tracts is associated with scores on the CPC-Q, adding to the validation evidence for this new questionnaire. White matter regions that may be related to posterior cortical symptoms detected by the CPC-Q, and distinct from those affected in amnestic syndromes, include the posterior thalamic radiations and body and splenium of the corpus callosum. These findings are in line with previous neuroimaging studies of PCA and support continued research on white matter in posterior cortical dysfunction.
- 1 January 2023
- Published by Wolters Kluwer Health in Alzheimer Disease & Associated Disorders
- Vol. 37 (1) , 50-58
Research Priorities of Individuals and Caregivers With Lewy Body Dementia
Introduction: Lewy body dementia (LBD) is common, yet under-recognized and under-researched. To plan studies with the highest impact, engagement of the community personally affected by these conditions is essential. Methods: A web-based survey of people living with LBD and current and former caregivers of people with LBD queried research priorities through forced ranking and exploration of burden of LBD symptoms. Specific caregiving needs in LBD and perceptions of research participation were also investigated. Results: Between April 7, 2021 and July 1, 2021, 984 responses were recorded. Top research priorities included disease-modifying therapies and improved disease detection and staging. People with LBD were interested in pathophysiology and more bothered by motor symptoms; caregivers were interested in risk factors and symptomatic therapies and more bothered by neuropsychiatric symptoms. Few available LBD treatments and resources were rated as helpful, and many valuable services were never received. Previous participation in LBD research was infrequent, but interest was high. Discussion: People with LBD and caregivers highlighted the need for research across all aspects of LBD, from pathophysiology and disease modification to prognosis, education, symptomatic treatments, and caregiver support. Funders should increase support for all aspects of LBD research to target the many needs identified by individuals and families living with LBD.
- 1 January 2023
- Published by Wolters Kluwer Health in Alzheimer Disease & Associated Disorders
- Vol. 37 (1) , 50-58
Research Priorities of Individuals and Caregivers With Lewy Body Dementia
Introduction: Lewy body dementia (LBD) is common, yet under-recognized and under-researched. To plan studies with the highest impact, engagement of the community personally affected by these conditions is essential. Methods: A web-based survey of people living with LBD and current and former caregivers of people with LBD queried research priorities through forced ranking and exploration of burden of LBD symptoms. Specific caregiving needs in LBD and perceptions of research participation were also investigated. Results: Between April 7, 2021 and July 1, 2021, 984 responses were recorded. Top research priorities included disease-modifying therapies and improved disease detection and staging. People with LBD were interested in pathophysiology and more bothered by motor symptoms; caregivers were interested in risk factors and symptomatic therapies and more bothered by neuropsychiatric symptoms. Few available LBD treatments and resources were rated as helpful, and many valuable services were never received. Previous participation in LBD research was infrequent, but interest was high. Discussion: People with LBD and caregivers highlighted the need for research across all aspects of LBD, from pathophysiology and disease modification to prognosis, education, symptomatic treatments, and caregiver support. Funders should increase support for all aspects of LBD research to target the many needs identified by individuals and families living with LBD.